IFFERA ZAHID: Open Payments
NPI 1386282135 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 124 payments from 20 companies in 2025. Trend: 2023 $2,245 · 2024 $1,020 · 2025 $2,336
Food & beverage: $2,336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $452 |
| E.R. Squibb & Sons, L.L.C. | 18 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $222 |
| Alkermes, Inc. | 10 | $191 |
| Neurocrine BioSciences, Inc. | 10 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Corium, LLC | 9 | $150 |
| Janssen Pharmaceuticals, Inc | 7 | $138 |
| Lundbeck LLC | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
Products named: VRAYLAR, COBENFY, CAPLYTA, INGREZZA, ARISTADA, Azstarys, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
